McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is cited in a June 22, 2017 edition of Life Sciences Intellectual Property Review in an article entitled, “BIO 2017: Industry at a crossroads over section 101.” The biotechnology industry is at a crossroads over 35 USC section 101, which covers patent subject matter eligibility. View the article